Ameritas Investment Partners’s American Renal Associates Holdings, Inc ARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,530
Closed -$18K 3109
2020
Q4
$18K Hold
1,530
﹤0.01% 2545
2020
Q3
$11K Hold
1,530
﹤0.01% 2696
2020
Q2
$10K Hold
1,530
﹤0.01% 2754
2020
Q1
$10K Hold
1,530
﹤0.01% 2576
2019
Q4
$16K Hold
1,530
﹤0.01% 2534
2019
Q3
$10K Buy
1,530
+850
+125% +$6.34K ﹤0.01% 2770
2019
Q2
$5K Hold
680
﹤0.01% 2960
2019
Q1
$4K Hold
680
﹤0.01% 2902
2018
Q4
$8K Hold
680
﹤0.01% 2762
2018
Q3
$15K Hold
680
﹤0.01% 2673
2018
Q2
$11K Hold
680
﹤0.01% 2825
2018
Q1
$13K Hold
680
﹤0.01% 2644
2017
Q4
$12K Hold
680
﹤0.01% 2699
2017
Q3
$9K Hold
680
﹤0.01% 2828
2017
Q2
$13K Hold
680
﹤0.01% 2721
2017
Q1
$11K Buy
+680
New +$13.6K ﹤0.01% 2672

Ameritas Investment Partners's ARA Position: Q1 2021 in Review

Ameritas Investment Partners sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 1,530 shares — an estimated $18K sold.

Ameritas Investment Partners first reported a position in ARA in Q1 2017 and held it in 16 quarters. The position peaked at $18K in Q4 2020. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.

  • Ameritas Investment Partners reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
  • Ameritas Investment Partners sold 1,530 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $18K.
  • Ameritas Investment Partners first reported a position in American Renal Associates Holdings, Inc in Q1 2017 and held it in 16 quarters.
  • Ameritas Investment Partners's American Renal Associates Holdings, Inc position peaked at $18K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.

Based on Ameritas Investment Partners's 13F filing for Q1 2021, filed 14 May 2021.